Microbial gut flora

The **microbial gut flora** (gut microbiota, gut microbiome) refers to the diverse and dynamic consortium of trillions of microorganisms—primarily bacteria, but also archaea, viruses, and fungi—residing in the gastrointestinal tract of humans and animals[2][4][5]. This community plays crucial roles in host digestion, metabolism, immune system regulation, barrier function, and protection against pathogens[2][5]. There is growing recognition of bidirectional communication between the gut microbiota and other organ systems, notably the brain (“microbiota–gut–brain axis”)[1][2]. Disruption of gut microbiota composition (dysbiosis) is implicated in a range of diseases, including inflammatory bowel disease, metabolic syndrome, obesity, neurodegenerative disorders (such as Alzheimer’s), and certain infections and cancers[1][2][3][4]. Therapeutic modulation of the gut microbiota includes use of antibiotics, probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, often aiming to restore eubiosis or target specific microbial interactions and metabolites[2][3][4][5]. The gut microbiota is not a conventional single molecular target like a receptor or enzyme, but rather a complex ecological system; as such, it is not considered a “therapeutic target” in the conventional sense (i.e., one gene/protein), although interventions “target” its community structure and function[2][4]. Structured pharmacological targeting is challenging due to complexity, redundancy, and inter-individual variability within the microbial ecosystem. Because “microbial gut flora” is not a single molecule, receptor, or protein, but rather a collective interactive ecosystem, it should not be catalogued as a canonical drug target. Instead, it is a modifiable system-level determinant of health and disease[2][5].

Other names

Gut microbiotaGut microbiomeIntestinal microbiotaIntestinal microfloraCommensal gut bacteriaFecal microbiota

Direct modulation of microbial composition (additive: probiotics, subtractive: antibiotics); Modulation of microbial metabolites (e.g., alteration of short-chain fatty acid production); Restoration of microbial diversity (e.g., via fecal microbiota transplantation); Immune regulation via changes in microbe-associated molecular patterns (MAMPs; e.g., LPS, peptidoglycan).